David Gillatt

13.0k total citations
163 papers, 5.6k citations indexed

About

David Gillatt is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, David Gillatt has authored 163 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Pulmonary and Respiratory Medicine, 51 papers in Surgery and 38 papers in Oncology. Recurrent topics in David Gillatt's work include Prostate Cancer Treatment and Research (47 papers), Prostate Cancer Diagnosis and Treatment (44 papers) and Bladder and Urothelial Cancer Treatments (30 papers). David Gillatt is often cited by papers focused on Prostate Cancer Treatment and Research (47 papers), Prostate Cancer Diagnosis and Treatment (44 papers) and Bladder and Urothelial Cancer Treatments (30 papers). David Gillatt collaborates with scholars based in United Kingdom, Australia and United States. David Gillatt's co-authors include David O. Bates, Raj Persad, Steven J. Harper, Jon Oxley, Angela M. Cottrell, Marto Sugiono, Mathias Winkler, Jacqueline D. Shields, T. J. Peters and Danielle Peat and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David Gillatt

152 papers receiving 5.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Gillatt 1.8k 1.7k 1.2k 1.1k 749 163 5.6k
Giuseppe Di Lorenzo 3.0k 1.6× 1.6k 0.9× 1.6k 1.3× 1.6k 1.4× 1.0k 1.4× 310 7.1k
Hong‐Jeng Yu 1.6k 0.9× 3.3k 1.9× 1.1k 1.0× 742 0.7× 849 1.1× 240 7.2k
Giovanni Luca Gravina 1.2k 0.6× 2.2k 1.3× 475 0.4× 1.3k 1.1× 783 1.0× 187 5.2k
Theodore M. Danoff 1.1k 0.6× 2.7k 1.6× 1.0k 0.9× 1.1k 1.0× 503 0.7× 47 6.7k
Nicola Longo 1.6k 0.9× 1.1k 0.6× 987 0.8× 588 0.5× 353 0.5× 242 4.1k
Kazutoshi Fujita 1.6k 0.8× 2.1k 1.2× 1.2k 1.0× 892 0.8× 1.0k 1.3× 262 5.1k
Jan‐Erik Damber 4.1k 2.2× 2.3k 1.3× 1.2k 1.0× 1.7k 1.5× 1.3k 1.7× 261 8.6k
Sergio Serni 3.1k 1.7× 2.0k 1.2× 1.4k 1.2× 1.5k 1.4× 974 1.3× 247 7.0k
Tanya B. Dorff 1.9k 1.0× 1.4k 0.8× 879 0.7× 1.6k 1.4× 820 1.1× 288 5.2k
J. Brantley Thrasher 3.2k 1.8× 1.8k 1.0× 1.7k 1.4× 966 0.9× 725 1.0× 134 6.6k

Countries citing papers authored by David Gillatt

Since Specialization
Citations

This map shows the geographic impact of David Gillatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gillatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gillatt more than expected).

Fields of papers citing papers by David Gillatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gillatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gillatt. The network helps show where David Gillatt may publish in the future.

Co-authorship network of co-authors of David Gillatt

This figure shows the co-authorship network connecting the top 25 collaborators of David Gillatt. A scholar is included among the top collaborators of David Gillatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gillatt. David Gillatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Pagano, Lisa, Andrew Hirschhorn, Emilie Francis‐Auton, et al.. (2023). Implementation of consensus-based perioperative care pathways to reduce clinical variation for elective surgery in an Australian private hospital: a mixed-methods pre–post study protocol. BMJ Open. 13(7). e075008–e075008. 2 indexed citations
4.
Chung, Eric T., et al.. (2023). Novoglan device for treatment of adult phimosis: Novoglan-01 open-label clinical trial on safety, efficacy and tolerability. Translational Andrology and Urology. 12(7). 1050–1061.
5.
Shore, Neal D., Christopher Pieczonka, Ralph J. Henderson, et al.. (2023). Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer. Urologic Oncology Seminars and Original Investigations. 41(11). 454.e9–454.e16. 2 indexed citations
6.
Campbell, Douglas Houghton, Maria E. Lund, Yanling Lü, et al.. (2020). The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors. Photodiagnosis and Photodynamic Therapy. 32. 102064–102064. 7 indexed citations
7.
Shore, Neal D., Christopher Pieczonka, Ralph J. Henderson, et al.. (2020). Development and evaluation of the MiCheck test for aggressive prostate cancer. Urologic Oncology Seminars and Original Investigations. 38(8). 683.e11–683.e18. 4 indexed citations
8.
Campbell, Douglas Houghton, Lucinda S. McRobb, Maria E. Lund, et al.. (2020). Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab®-IRDye800CW as a Potential Tool for Fluorescence-Guided Surgery. Cancers. 12(4). 984–984. 17 indexed citations
9.
Liang, Liuen, Andrew Care, Anwar Sunna, et al.. (2019). Functionalized Upconversion Nanoparticles for Targeted Labelling of Bladder Cancer Cells. Biomolecules. 9(12). 820–820. 17 indexed citations
10.
Lane, J. Athene, Vanessa Er, Kerry Avery, et al.. (2018). ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate Cancer. Cancer Prevention Research. 11(11). 687–696. 33 indexed citations
11.
Rapport, Frances, Anne Hogden, Howard Gurney, et al.. (2017). Communicating risk in active surveillance of localised prostate cancer: a protocol for a qualitative study. BMJ Open. 7(10). e017372–e017372. 1 indexed citations
12.
Goonewardene, Sanchia S., Annie Young, Raj Persad, & David Gillatt. (2016). Prostate Cancer Survivorship and Psychosexual Care: A Systematic Review for a Continuously Evolving Field. 2016(1).
13.
Thurairaja, Ramesh, et al.. (2014). Pathological analysis of lymph nodes in anterior prostatic fat excised at robot-assisted radical prostatectomy. Journal of Clinical Pathology. 67(9). 787–791. 10 indexed citations
14.
Biernacka, Kalina, Li Zeng, Amit Bahl, et al.. (2013). Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2. Endocrine Related Cancer. 20(5). 741–751. 71 indexed citations
15.
Gillatt, David. (2009). Painful bladder and urinary tract pathology associated with long term ketamine use. Neurourology and Urodynamics. 1 indexed citations
16.
Oliver, Steven, Kieran Jefferson, David Gunnell, et al.. (2003). IGF-axis and screen-detected prostate cancer: A cross-sectional study. The Journal of Urology. 169. 161–161. 1 indexed citations
17.
Gunnell, David, Steven Oliver, J L Donovan, et al.. (2002). Are diet-prostate cancer associations mediated by insulin-like growth factors? Cross-sectional analysis of diet-IGF associations in middle-aged men. Cancer Epidemiology Biomarkers & Prevention. 11.
18.
Muschter, Rolf, et al.. (1996). Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia. Urology. 48(2). 223–228. 37 indexed citations
19.
Eckford, S. D. & David Gillatt. (1992). Abdominal Aortic Aneurysms Presenting as Renal Colic. British Journal of Urology. 70(5). 496–498. 13 indexed citations
20.
Ward, A.J. & David Gillatt. (1989). Delayed diagnosis of traumatic rupture of the spleen—a warning of the use of thoracic epidural analgesia in chest trauma. Injury. 20(3). 178–179. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026